Weekly epirubicin plus lonidamine in advanced breast carcinoma

被引：0
|
作者：
Cecilia Nisticò
Carlo Garufi
Michele Milella
Anna Maria D'Ottavio
Angela Vaccaro
Alessandra Fabi
Edmondo Terzoli
机构：
[1] Regina Elena Cancer Institute,Service of Complementary Medical Oncology
[2] Regina Elena Cancer Institute,Division of Medical Oncology I
来源：
Breast Cancer Research and Treatment | 1999年 / 56卷 / 3期
关键词：
advanced breast cancer; epirubicin; lonidamine; weekly schedule;
D O I：
10.1023/A:1006213815195
中图分类号：
学科分类号：
摘要：
Lonidamine has been demonstrated to potentiate the cytotoxic activity of several antineoplastic drugs, for example anthracyclines. Moreover, epirubicin is considered one of the most active drugs in advanced breast cancer, although optimal dose and schedule remains to be defined.
引用
收藏
页码：231 / 235
页数：4
相关论文
共 50 条
  • [1] Weekly epirubicin plus lonidamine in advanced breast carcinoma
    Nisticò, C
    Garufi, C
    Milella, M
    D'Ottavio, AM
    Vaccaro, A
    Fabi, A
    Terzoli, E
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1999, 56 (03) : 233 - 237
  • [2] Lonidamine plus epirubicin and cyclophosphamide in advanced breast cancer. A phase II study
    Gardin, G
    Barone, C
    Nascimben, O
    Ianniello, G
    Sturba, F
    Contu, A
    Pronzato, P
    Rosso, R
    [J]. EUROPEAN JOURNAL OF CANCER, 1996, 32A (01) : 176 - 177
  • [3] Epirubicin vs epirubicin plus cisplatin vs epirubicin plus lonidamine vs epirubicin plus cisplatin plus lonidamine as first line treatment in advanced breast cancer (BC) patients. A randomized multicenter phase III trial with a factorial design.
    Dogliotti, L
    Berruti, A
    Bitossi, R
    Gorzegno, G
    Bottini, A
    Alquati, P
    De Matteis, A
    Nuzzo, F
    Giardina, B
    Danese, S
    De Lena, M
    Lorusso, V
    Farris, A
    Sarobba, MG
    DeFabiani, E
    Spanu, G
    Bonazzi, G
    Castiglione, F
    Bumma, C
    Moro, G
    Galletto, L
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 41 - 41
  • [4] COMBINATION OF EPIRUBICIN AND LONIDAMINE FOR TREATMENT OF ADVANCED BREAST-CANCER
    MORAGLIO, L
    BREMA, F
    PASTORINO, G
    MARTINI, MC
    VALLAURI, M
    [J]. TUMORI, 1995, 81 (02) : 107 - 111
  • [5] WEEKLY EPIRUBICIN IN ADVANCED BREAST-CANCER
    TUCCI, E
    ALGERI, R
    GUARNIERI, A
    PEPI, F
    SAPIO, L
    BASTREGHI, G
    PIRTOLI, L
    [J]. TUMORI, 1988, 74 (06) : 689 - 692
  • [6] Cisplatin plus epirubicin plus paclitaxel weekly regimen in advanced breast cancer: A phase I study
    Frasci, G
    Manzione, L
    Comella, P
    D'Aiuto, G
    Capasso, I
    Carteni, G
    Thomas, R
    Pacilio, C
    Apicella, A
    Gravina, A
    Guida, T
    Di Bonito, M
    Piccolo, S
    Comella, G
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 15 - 16
  • [7] Increased feasibility of weekly epirubicin and paclitaxel as neoadjuvant chemotherapy for locally advanced breast carcinoma
    Chen, SC
    Chang, HK
    Lin, YC
    Cheung, YC
    Tsai, CS
    Leung, WM
    Hsueh, S
    Chen, MF
    [J]. ONKOLOGIE, 2005, 28 (6-7): : 339 - 344
  • [8] EPIRUBICIN TREATMENT OF ADVANCED BREAST-CARCINOMA WITH THE WEEKLY LOW-DOSE REGIMEN
    BERETTA, G
    LOCATELLI, C
    TABIADON, D
    LABIANCA, R
    FRASCHINI, P
    LUPORINI, G
    [J]. ONCOLOGY, 1987, 44 (01) : 6 - 12
  • [9] Paclitaxel plus epirubicin in advanced breast cancer
    Conte, PF
    Gennari, A
    Salvadori, B
    Pazzagli, I
    Bengala, C
    [J]. ONCOLOGY-NEW YORK, 1998, 12 (01): : 40 - 44
  • [10] EPIRUBICIN (EPIDX) WEEKLY IN THE TREATMENT OF ADVANCED BREAST-CANCER
    LOMBARDI, F
    FACCENDINI, E
    RINALDI, E
    LANZETTI, V
    MEREGHETTI, M
    NEGRETTI, S
    BIASIOLI, R
    [J]. TUMORI, 1986, 72 (06) : 714 - 714
12345